Plasmapheresis Clinical Trials
2 recruitingProcedure
Phase 21Not Applicable1
Showing 1–2 of 2 trials
Recruiting
Phase 2
Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers
Stage IV Bladder Cancer AJCC v7Metastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis and Ureter Urothelial Carcinoma+3 more
Mayo Clinic70 enrolled1 locationNCT07087860
Recruiting
Not Applicable
Plasmapheresis in Amyotrophic Lateral Sclerosis With Autoantibody Against NRIP
Amyotrophic Lateral SclerosisPlasmapheresis
National Taiwan University Hospital20 enrolled1 locationNCT05562960